JAJeffry R. Alger

Jeffry R. Alger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jeffry R. Alger has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Anterior Middle Cingulate Cortex Gamma‐Aminobutyric Acid Level Is Elevated in Children With Attention Deficit Hyperactivity Disorder With and Without Prenatal Alcohol Exposure

    by Jeffry R. Alger, Ishika Gupta, Lea Farkouh, Jennifer Korthas, Ankita Shah, Arjun B. Silverberg, Noriko Salamon, Benjamin N. Schneider, Shantanu H. Joshi, Mary J. O'COnnor, et al.

    Background: Prior neuroimaging suggests brain differences between children with attention deficit hyperactivity disorder and prenatal alcohol exposure (ADHD+PAE) and non‐exposed children with ADHD due to non‐PAE causes (ADHD‐PAE). There has been interest in regional brain levels of gamma‐aminobutyric acid (GABA) and glutamate (Glu) measured in vivo with magnetic resonance spectroscopy (MRS) as possible indicators of local inhibitory, respectively, excitatory activity in ADHD. For the first time, we report here a comparison of GABA and Glu in ADHD+PAE vs. ADHD‐PAE. Methods: At 3 Tesla, we used J‐difference‐edited single‐voxel MRS to assay GABA and Glu in 27 children with ADHD+PAE, 21 with ADHD‐PAE, and 28 typically developing (TD) controls, all aged between 7 and 14 years. MRS was sampled from midline anterior middle cingulate cortex (aMCC), the “cognitive cingulate” considered functionally relevant to ADHD. Spectra were fit with custom software, including a unique technique for isolating the GABA signal from the confounding macromolecular baseline (MMBL). Results: aMCC GABA was higher in ADHD+PAE and ADHD‐PAE than in TD. GABA increased with age in TD, but not in ADHD+PAE or ADHD‐PAE. Similar effects were observed for the ratios GABA/Glu and GABA/Glx. For GABA+MMBL (GABA+) these effects were not seen; rather, GABA+ and MMBL increased with age for the ADHD+PAE group only. No significant effects were found for Glu or Glx. Conclusions: GABA in the aMCC does not distinguish the two etiologies of ADHD; rather, elevated GABA that follows an abnormal development appears to be common to both. High GABA may reflect increased inhibition of the aMCC impairing its cognitive functions. GABA+ results in ADHD may not track reliably with underlying GABA values. Negative results for Glu and Glx should be reexamined at shorter echo‐times.

  • Open Access

    Anterior middle cingulate cortex gamma-aminobutyric acid level is elevated in children with both familial and prenatal alcohol exposure-associated attention deficit hyperactivity disorder

    by Jeffry R. Alger, Ishika Gupta, Lea Farkouh, Jennifer Korthas, Ankita Shah, Arjun Silverberg, Noriko Salamon, Benjamin N. Schneider, Shantanu H. Joshi, Mary J. O’COnnor, et al.

    Background: Prior neuroimaging suggests brain differences between children with attention deficit hyperactivity disorder due to prenatal alcohol exposure (ADHD+PAE) and non-exposed children with ADHD due to other, e.g., familial, causes (ADHD-PAE). There has been interest in regional brain levels of gamma-aminobutyric acid (GABA) and glutamate (Glu) measured in vivo with magnetic resonance spectroscopy (MRS) as possible indicators of local inhibitory, respectively, excitatory activity in ADHD. For the first time, we report here a comparison of GABA and Glu in ADHD+PAE vs. ADHD-PAE. Methods: At 3 T, we used J-difference-edited single-voxel MRS to assay GABA and Glu in 28 children with ADHD+PAE, 20 with ADHD-PAE, and 28 typically developing (TD) controls, all aged 8-14 years. MRS was sampled from midline anterior middle cingulate cortex (aMCC), the “cognitive cingulate” considered functionally relevant to ADHD. Spectra were fit with custom software, including a unique technique for isolating the GABA signal from the confounding macromolecular baseline (MMBL). Results: aMCC GABA was higher in ADHD+PAE and ADHD-PAE than in TD. GABA increased with age in TD, but not in ADHD+PAE or ADHD-PAE. Similar effects were observed for the ratios GABA/Glu and GABA/Glx. For GABA+MMBL (GABA+) these effects were not seen, rather GABA+ and MMBL increased with age for the ADHD+PAE group only. No significant effects were found for Glu or Glx. Conclusions: GABA in the aMCC does not distinguish the two etiologies of ADHD, rather elevated GABA that follows an abnormal developmental appears to be common to both. High GABA may reflect increased inhibition of the aMCC impairing its cognitive functions. GABA+ results in ADHD may not tract reliably with underlying GABA values. Negative results for Glu and Glx should be reexamined at shorter echo-times.

  • Open Access

    Distinct Resting-State Functional Connectivity Profiles in ADHD with and without Prenatal Alcohol Exposure

    by Ishika Gupta, Lea Farkouh, Lisa Kilpatrick, Jennifer Korthas, Noriko Salamon, Benjamin N. Schneider, Shantanu H. Joshi, Jeffry R. Alger, Mary J. O’COnnor, Joseph O’NEill

    Aim: To determine whether the neural phenotype (whole-brain resting-state functional connectivity pattern) of attention-deficit/hyperactivity disorder associated with prenatal alcohol exposure (ADHD-PAE) differs from that in unexposed children with ADHD of probable familial origin (ADHD-PAE). Method: Resting-state functional MRI was acquired from 26 children with ADHD+PAE, 25 with ADHD-PAE and 25 typically developing (TD) children, all aged 8-13 years. Mean connectivity matrices based on the Cole-Anticevic Brainwide Network Parcellation of the brain were compared between the groups. Results: Within the frontoparietal network (FPN), children with ADHD+PAE showed widespread lower group-mean connectivity than children with ADHD–PAE; effects were concentrated primarily in cerebellar–cerebral cortical and cerebral cortical–cerebral cortical connections. Children with ADHD–PAE showed widespread hyperconnectivity relative to TD children. Children with ADHD+PAE showed mixed hyper- and hypoconnectivity relative to TD. Interpretation: These results are consistent with other MRI findings indicating that ADHD+PAE is neurally distinct from ADHD-PAE; PAE may be associated with broadly reduced connectivity, especially across cerebellar–cerebral cortical systems.


  • Open Access

    Trigeminal nerve stimulation (TNS) for children with attention deficit/hyperactivity disorder and fetal alcohol spectrum disorder: Feasibility study protocol

    by Joseph O’nEill, Shantanu Joshi, Jeffry R. Alger, Andrew F. Leuchter, Benjamin N. Schneider, Mary J. O’cOnnor

    Symptoms of attention deficit/hyperactivity disorder (ADHD) are common, severe and highly impairing in children with prenatal alcohol exposure (PAE), but often non-responsive to medication, leaving many with no good treatment. External trigeminal nerve stimulation (TNS) is a minimal risk, non-invasive neuromodulatory intervention that is FDA-cleared for ADHD. No formal trial, however, has tested TNS in children with known PAE. We present here the protocol of the first clinical trial of TNS in children with ADHD associated with PAE. The study also uses multimodal MRI to explore possible brain mechanisms of TNS. An open-label pilot will be conducted of 4 weeks of TNS in 30 youth with ADHD associated with PAE, recruited in Southern California. Children will receive TNS nightly for 4 weeks. Safety, tolerability, and preliminary efficacy will be evaluated. Efficacy outcomes include change in the investigator-administered parent-rated ADHD Rating Scale and the Clinical Global Impression Improvement (CGI-I) score for ADHD. Effects on executive function, mood, and sleep are also assessed. Maintenance of effects is evaluated at 4-week follow-up. TNS-related brain changes and predictors of response are measured using structural MRI, diffusion tensor imaging (DTI), magnetic resonance spectroscopy (MRS), and resting-state fMRI before and after treatment. This study will determine whether TNS is feasible in children with ADHD and PAE, whether it improves clinical and cognition symptoms, and whether efficacy persists 4 weeks. Trial registration: clinicaltrials.gov (NCT06847165) and protocol ID: IRB-24–0648-AM-007 June 16, 2025.

  • Open Access

    Trigeminal Nerve Stimulation (TNS) for Children with Attention Deficit/Hyperactivity Disorder and Fetal Alcohol Spectrum Disorder: Feasibility Study Protocol

    by Joseph O’neill, Shantanu Joshi, Jeffry R Alger, Benjamin N Schneider, Mary J O’connor

    Symptoms of attention deficit/hyperactivity disorder (ADHD) are common, severe and highly impairing in children with prenatal alcohol exposure (PAE), but often non-responsive to medication, leaving many with no beneficial treatment. External trigeminal nerve stimulation (TNS) is a minimal risk, non-invasive neuromodulatory intervention that is FDA-cleared for ADHD. No formal trial, however, has tested TNS in children with known PAE. We present here the protocol of the first clinical trial of TNS in children with ADHD associated with PAE. The study also uses multimodal MRI to explore possible brain mechanisms of TNS. An open-label pilot will be conducted of 4 weeks of TNS in 30 youth with ADHD associated with PAE, recruited in Southern California. Children will receive TNS nightly for 4 weeks. Safety, tolerability, and preliminary efficacy will be evaluated. Efficacy outcomes include change in the physician-administered parent-rated ADHD Rating Scale and the Clinical Global Impression Improvement (CGI-I) score for ADHD. Effects on executive function, mood, and sleep are also assessed. Maintenance of effects is evaluated at 4-week follow-up. TNS-related brain changes and predictors of response are measured using structural MRI, diffusion tensor imaging (DTI), magnetic resonance spectroscopy (MRS), and resting-state fMRI before and after treatment. This study will determine whether TNS is feasible in children with ADHD and PAE, whether it improves clinical and cognition symptoms, and whether efficacy persists 4 weeks. Trial registration: clinicaltrials.gov ( NCT06847165 ) and protocol ID: IRB-24-0648-AM-007 June 16, 2025.

  • Deep Learning Denoising Improves CT Perfusion Image Quality in the Setting of Lower Contrast Dosing: A Feasibility Study

    by Mahmud Mossa-Basha, Chengcheng Zhu, Tanya Pandhi, Steve Mendoza, Javid Azadbakht, Ahmed Safwat, Dean Homen, Carlos Zamora, Dinesh Kumar Gnanasekaran, Ruiyue Peng, et al.

    BACKGROUND AND PURPOSE: Considering recent iodinated contrast media (ICM) shortages, this study compared reduced ICM and standard dose CTP acquisitions, and the impact of deep learning (DL)-denoising on CTP image quality in preclinical and clinical studies. MATERIALS AND METHODS: Twelve swine underwent 9 CTP exams each, performed at combinations of 3 different X-ray (37, 67, and 127mAs) and ICM doses (10, 15, and 20mL). Clinical CTP acquisitions performed before and during the ICM shortage and protocol change (from 40 mL to 30 mL) were retrospectively included. Eleven patients with reduced ICM dose and 11 propensity-score-matched controls with standard ICM dose were included. A Residual Encoder-Decoder Convolutional-Neural-Network (RED-CNN) was trained for CTP denoising using K-space-Weighted Image Average (KWIA) filtered CTP images as the target. The standard, RED-CNN denoised, and KWIA noise-filtered images for animal and human studies were compared for quantitative SNR and qualitative image evaluation. RESULTS: The SNR of animal CTP images decreased with reductions in ICM and mAs doses. Contrast dose reduction had a greater effect on SNR than mAs reduction. Noise-filtering by KWIA and RED-CNN denoising progressively improved SNR of CTP maps, with RED-CNN resulting in the highest SNR. The SNR of clinical CTP images was generally lower with reduced ICM dose, which was improved by KWIA and RED-CNN denoising (p<0.05). Qualitative readings consistently rated RED-CNN denoised CTP as best quality, followed by KWIA and then standard CTP images. CONCLUSIONS: DL-denoising can improve image quality for low ICM CTP protocols, and could approximate standard ICM dose CTP, in addition to potentially improving image quality for low mAs acquisitions. ABBREVIATIONS: ICM=iodinated contrast media; DL=deep learning; KWIA=k-space weighted image average; LCD=low-contrast dose; SCD=standard contrast dose; RED-CNN=Residual Encoder-Decoder Convolutional Neural Network; PSNR=Peak Signal to Noise Ratio; RMSE=Root Mean Squared Error; SSIM=Structural Similarity Index.


  • Analysis of steady-state carbon tracer experiments using akaike information criteria

    by Jeffry R. Alger, Abu Minhajuddin, A. Dean Sherry, Craig R. Malloy

    Introduction Carbon isotope tracers have been used to determine relative rates of tricarboxylic acid cycle (TCA) cycle pathways since the 1950s. Steady-state experimental data are typically fit to a single mathematical model of metabolism to determine metabolic fluxes. Whether the chosen model is appropriate for the biological system has generally not been evaluated systematically. An overly-simple model omits known pathways while an overly-complex model may produce incorrect results due to overfitting. Objectives The objectives were to develop and study a method that systematically evaluates multiple TCA cycle mathematical models as part of the fitting process. Methods The problem of choosing overly-simple or overly-complex models was approached by developing software that automatically explores all possible combinations of flux through pyruvate dehydrogenase, pyruvate kinase, pyruvate carboxylase and anaplerosis at propionyl-CoA carboxylase, and equivalent pathways, all relative to TCA cycle flux. Typical TCA cycle metabolic tracer experiments that use 13C nuclear magnetic resonance for detection and quantification of 13C-enriched glutamate products were simulated and analyzed. By evaluating the multiple model fits with both the conventional sum-of-squares residual error (SSRE) and the Akaike Information Criterion (AIC), the software helps the investigator understand the interaction between model complexity and goodness of fit. Results When fitting alternative models of the TCA cycle metabolism, the SSRE may identify more than one model that fits the data well. Among those models, the AIC provides guidance as to which is the simplest of the candidate models is sufficient to describe the observed data. However under some conditions, AIC used alone inappropriately discriminates against necessary metabolic complexity. Conclusion In combination, the SSRE and AIC help the investigator identify the model that best describes the metabolism of a biological system.


  • Open Access

    Cortical gyrification in children with attention deficit-hyperactivity disorder and prenatal alcohol exposure

    by Lisa A. Kilpatrick, Shantanu H. Joshi, Joseph O’NEill, Guldamla Kalender, Andrea Dillon, Karin M. Best, Katherine L. Narr, Jeffry R. Alger, Jennifer G. Levitt, Mary J. O’COnnor


  • Neuroimaging of Supraventricular Frontal White Matter in Children with Familial Attention-Deficit Hyperactivity Disorder and Attention-Deficit Hyperactivity Disorder Due to Prenatal Alcohol Exposure

    by Jeffry R. Alger, Joseph O’nEill, Mary J. O’cOnnor, Guldamla Kalender, Ronald Ly, Andrea Ng, Andrea Dillon, Katherine L. Narr, Sandra K. Loo, Jennifer G. Levitt

    Attention-deficit hyperactivity disorder (ADHD) is common in patients with (ADHD+PAE) and without (ADHD-PAE) prenatal alcohol exposure (PAE). Many patients diagnosed with idiopathic ADHD actually have covert PAE, a treatment-relevant distinction. To improve differential diagnosis, we sought to identify brain differences between ADHD+PAE and ADHD-PAE using neurobehavioral, magnetic resonance spectroscopy, and diffusion tensor imaging metrics that had shown promise in past research. Children 8–13 were recruited in three groups: 23 ADHD+PAE, 19 familial ADHD-PAE, and 28 typically developing controls (TD). Neurobehavioral instruments included the Conners 3 Parent Behavior Rating Scale and the Delis-Kaplan Executive Function System (D-KEFS). Two dimensional magnetic resonance spectroscopic imaging was acquired from supraventricular white matter to measure N-acetylaspartate compounds, glutamate, creatine + phosphocreatine (creatine), and choline-compounds (choline). Whole brain diffusion tensor imaging was acquired and used to to calculate fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity from the same superventricular white matter regions that produced magnetic resonance spectroscopy data. The Conners 3 Parent Hyperactivity/Impulsivity Score, glutamate, mean diffusivity, axial diffusivity, and radial diffusivity were all higher in ADHD+PAE than ADHD-PAE. Glutamate was lower in ADHD-PAE than TD. Within ADHD+PAE, inferior performance on the D-KEFS Tower Test correlated with higher neurometabolite levels. These findings suggest white matter differences between the PAE and familial etiologies of ADHD. Abnormalities detected by magnetic resonance spectroscopy and diffusion tensor imaging co-localize in supraventricular white matter and are relevant to executive function symptoms of ADHD.


  • Open Access

    Whole Brain Magnetic Resonance Spectroscopic Determinants of Functional Outcomes in Pediatric Moderate/Severe Traumatic Brain Injury

    by Talin Babikian, Jeffry R. Alger, Monica U. Ellis-Blied, Christopher C. Giza, Emily Dennis, Alexander Olsen, Richard Mink, Christopher Babbitt, Jeffrey Johnson, Paul M. Thompson, et al.

    Diffuse axonal injury contributes to the long-term functional morbidity observed following pediatric moderate/severe traumatic brain injury (msTBI). Whole-Brain Proton Magnetic Resonance Echo-Planar Spectroscopic Imaging was used to measure the neurometabolite levels in the brain to delineate the course of disruption/repair during the first year post msTBI. The association between metabolite biomarkers and functional measures (cognitive functioning and CC function assessed by interhemispheric transfer time (IHTT) using an Event Related Potential paradigm) was also explored. Pediatric msTBI patients underwent assessments at two times (post-acutely at a mean of 3 months post-injury, n = 31 and chronically at a mean of 16 months post injury, n = 24). Healthy controls also underwent two evaluations, approximately 12 months apart. Post-acutely, in patients with msTBI there were elevations in choline (Cho; marker for inflammation and/or altered membrane metabolism) in all four brain lobes and the CC and decreases in N-acetylaspartate (NAA; marker for neuronal and axonal integrity) in the CC compared to controls, all of which normalized by the chronic time point. Subgroups of TBI showed variable patterns chronically. Patients with slow IHTT had lower lobar Cho chronically than those with normal IHTT; they also did not show normalization in CC NAA whereas those with normal IHTT showed significantly higher levels of CC NAA relative to controls. In the normal IHTT group only, chronic CC Cho and NAA together explained 70% of the variance in long-term cognitive functioning. MR based whole brain metabolic evaluations show different patterns of neurochemistry following msTBI in two subgroups with different outcomes. There is a dynamic relationship between prolonged inflammatory responses to brain damage, reparative processes/remyelination, and subsequent neurobehavioral outcomes. Multimodal studies allow us to test hypotheses about degenerative and reparative processes in patient groups that have divergent functional outcome, with the ultimate goal of developing targeted therapeutic agents.